ResearchMoz.us include new market research report "Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 " to its huge collection of research reports. Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Chile In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Directs team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Chile In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Chile In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
For More information, Please Visit@ Chile In Vitro Diagnostics Investment
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What is This Report About? 10
3 In Vitro Diagnostics In Chile 11
3.1 In Vitro Diagnostics, Chile, Overall Revenue ($m), USD Constant, 2004-2018 11
3.2 In Vitro Diagnostics, Chile, Company Share (2010-2011) 17
4 Clinical Chemistry In Chile 19
4.1 Clinical Chemistry Overall Revenue, (2004-2018) 19
4.1.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 23
4.1.2 Urine Analysis, Revenue (2004-2018) 27
4.2 Clinical Chemistry Distribution Share (2010-2011) 31
4.3 Clinical Chemistry, Chile, Company Share (2010-2011) 32
5 Genetic Testing In Chile 34
5.1 Genetic Testing Overall Revenue, (2004-2018) 34
5.2 Genetic Testing Distribution Share (2010-2011) 38
5.3 Genetic Testing, Chile, Company Share (2010-2011) 39
6 Haematology In Chile 41
6.1 Haematology Overall Revenue, (2004-2018) 41
6.1.1 Haematology Reagents, Revenue, (2004-2018) 45
6.1.2 Immunohaematology, Revenue (2004-2018) 49
6.1.3 Haemostasis, Revenue (2004-2018) 53
6.1.4 Haematology Rapid Tests, Revenue (2004-2018) 57
6.1.5 Haematology Cell Counters, Revenue (2004-2018) 61
6.2 Haematology Distribution Share (2010-2011) 65
6.3 Haematology, Chile, Company Share (2010-2011) 66
7 Histology And Cytology In Chile 68
7.1 Histology And Cytology Overall Revenue, (2004-2018) 68
7.2 Histology And Cytology Distribution Share (2010-2011) 72
7.3 Histology And Cytology, Chile, Company Share (2010-2011) 73
8 Immuno Chemistry In Chile 75
8.1.1 Immuno Chemistry Overall Revenue, (2004-2018) 75
8.1.2 Disease Specific Immunochemistry, Revenue (2004-2018) 79
8.1.3 Drugs of Abuse / Toxicology, Revenue (2004-2018) 83
8.1.4 Endocrinology Tests, Revenue (2004-2018) 87
8.1.5 Immunochemistry Rapid Tests, Revenue (2004-2018) 91
8.1.6 Therapeutic Drug Monitoring, Revenue (2004-2018) 95
8.1.7 Immunochemistry Analyzers, Revenue (2004-2018) 99
8.2 Immuno Chemistry Distribution Share (2010-2011) 103
8.3 Immuno Chemistry, Chile, Company Share (2010-2011) 104
9 Infectious Immunology In Chile 106
9.1 Infectious Immunology Overall Revenue, (2004-2018) 106
9.1.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 110
9.2 Infectious Immunology Distribution Share (2010-2011) 114
9.3 Infectious Immunology, Chile, Company Share (2010-2011) 115
See All Latest Market Research Reports@ http://www.researchmoz.us/report.html
10 Microbiology Culture In Chile 117
10.1 Microbiology Culture Overall Revenue, (2004-2018) 117
10.1.1 Microbiology Analyzers, Revenue (2004-2018) 121
10.2 Microbiology Culture Distribution Share (2010-2011) 125
10.3 Microbiology Culture, Chile, Company Share (2010-2011) 126
11 Overview of Key Companies in Chile In Vitro Diagnostics Market 128
11.1 F. Hoffmann-La Roche Ltd. 128
11.1.1 Company Overview 128
11.2 Siemens Healthcare 128
11.2.1 Company Overview 128
11.3 Abbott Laboratories 129
11.3.1 Company Overview 129
11.4 Beckman Coulter, Inc. 129
11.4.1 Company Overview 129
11.5 bioMerieux S.A. 130
11.5.1 Company Overview 130
11.6 Ortho-Clinical Diagnostics Inc. 130
11.6.1 Company Overview 130
11.7 Bio-Rad Laboratories, Inc. 131
11.7.1 Company Overview 131
11.8 Alere Inc. 131
11.8.1 Company Overview 131
11.9 Sysmex Corporation 132
11.9.1 Company Overview 132
11.10 Becton, Dickinson and Company 132
11.10.1 Company Overview 132
11.11 Mindray Medical International Limited 133
11.11.1 Company Overview 133
11.12 Horiba, Ltd. 133
11.12.1 Company Overview 133
11.13 DiaSorin S.p.A 134
11.13.1 Company Overview 134
11.14 Thermo Fisher Scientific Inc. 134
11.14.1 Company Overview 134
11.15 Qiagen N.V. 135
11.15.1 Company Overview 135
11.16 PerkinElmer, Inc. 135
11.16.1 Company Overview 135
11.17 Gen-Probe Incorporated 136
11.17.1 Company Overview 136
11.18 Olympus Corporation 136
11.18.1 Company Overview 136
11.19 Diagnostica Stago, Inc. 137
11.19.1 Company Overview 137
11.20 Grifols, S.A. 137
11.20.1 Company Overview 137
11.21 Phadia AB 138
11.21.1 Company Overview 138
12 Appendix 139
12.1 Global Markets Direct Research Methodology 139
12.2 Definitions of Markets Covered in the Report 140
12.2.1 In Vitro Diagnostics 140
12.3 Secondary Research 151
12.4 Primary Research 151
12.5 Models 152
12.6 Forecasts 152
12.7 Expert Panel Validation 152
12.8 Currency Conversion 153
12.9 Contact Us 153
12.10 Disclaimer 153
To know more about this reports, please visit @ http://www.researchmoz.us/chile-in-vitro-diagnostics-investment-opportunities-analysis-and-forecasts-to-2018-report.html
Contact: sales@researchmoz.us for further information.
No comments:
Post a Comment